{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:36:40Z","timestamp":1790696200525,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Streptococcus pneumoniae<\/jats:italic> serotype 1 is the predominant cause of invasive pneumococcal disease in sub-Saharan Africa, but the mechanism behind its increased invasiveness is not well understood. Here, we use mouse models of lung infection to identify virulence factors associated with severe bacteraemic pneumonia during serotype-1 (ST217) infection. We use BALB\/c mice, which are highly resistant to pneumococcal pneumonia when infected with other serotypes. However, we observe 100% mortality and high levels of bacteraemia within 24\u2009hours when BALB\/c mice are intranasally infected with ST217. Serotype 1 produces large quantities of pneumolysin, which is rapidly released due to high levels of bacterial autolysis. This leads to substantial levels of cellular cytotoxicity and breakdown of tight junctions between cells, allowing a route for rapid bacterial dissemination from the respiratory tract into the blood. Thus, our results offer an explanation for the increased invasiveness of serotype 1.<\/jats:p>","DOI":"10.1038\/s41467-020-15751-6","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T10:03:07Z","timestamp":1587376987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin"],"prefix":"10.1038","volume":"11","author":[{"given":"Laura C.","family":"Jacques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9972-5068","authenticated-orcid":false,"given":"Stavros","family":"Panagiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1972-2308","authenticated-orcid":false,"given":"Murielle","family":"Baltazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madikay","family":"Senghore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadia","family":"Khandaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bricio-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-8836","authenticated-orcid":false,"given":"Christopher G.","family":"Dowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8458-6779","authenticated-orcid":false,"given":"Dean B.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7911-8153","authenticated-orcid":false,"given":"Daniel R.","family":"Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1137-6321","authenticated-orcid":false,"given":"Aras","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"15751_CR1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","volume":"374","author":"KL O\u2019Brien","year":"2009","unstructured":"O\u2019Brien, K. L. et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374, 893\u2013902 (2009).","journal-title":"Lancet"},{"key":"15751_CR2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-2005-925523","volume":"26","author":"A Ortqvist","year":"2005","unstructured":"Ortqvist, A., Hedlund, J. & Kalin, M. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin. Respir. Crit. Care Med. 26, 563\u2013574 (2005).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"15751_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/fmb.11.146","volume":"7","author":"ND Ritchie","year":"2012","unstructured":"Ritchie, N. D., Mitchell, T. J. & Evans, T. J. What is different about serotype 1 pneumococci? Future Microbiol. 7, 33\u201346 (2012).","journal-title":"Future Microbiol."},{"key":"15751_CR4","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1016\/j.vaccine.2017.07.009","volume":"35","author":"C Chaguza","year":"2017","unstructured":"Chaguza, C. et al. Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi. Vaccine 35, 4594\u20134602 (2017).","journal-title":"Vaccine"},{"key":"15751_CR5","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1128\/JCM.41.11.4966-4970.2003","volume":"41","author":"AB Brueggemann","year":"2003","unstructured":"Brueggemann, A. B. & Spratt, B. G. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J. Clin. Microbiol. 41, 4966\u20134970 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"15751_CR6","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1987-z","volume":"16","author":"C Chaguza","year":"2016","unstructured":"Chaguza, C. et al. Understanding pneumococcal serotype 1 biology through population genomic analysis. BMC Infect. Dis. 16, 649 (2016).","journal-title":"BMC Infect. Dis."},{"key":"15751_CR7","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","volume":"190","author":"AB Brueggemann","year":"2004","unstructured":"Brueggemann, A. B. et al. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190, 1203\u20131211 (2004).","journal-title":"J. Infect. Dis."},{"key":"15751_CR8","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1097\/00002030-199816000-00013","volume":"12","author":"N Jones","year":"1998","unstructured":"Jones, N., Huebner, R., Khoosal, M., Crewe-Brown, H. & Klugman, K. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. AIDS 12, 2177\u20132184 (1998).","journal-title":"AIDS"},{"key":"15751_CR9","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1086\/515013","volume":"27","author":"JA Scott","year":"1998","unstructured":"Scott, J. A. et al. Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. Clin. Infect. Dis. 27, 1442\u20131450 (1998).","journal-title":"Clin. Infect. Dis."},{"key":"15751_CR10","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2006.09.009","volume":"25","author":"WP Hausdorff","year":"2007","unstructured":"Hausdorff, W. P. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine 25, 2406\u20132412 (2007).","journal-title":"Vaccine"},{"key":"15751_CR11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1128\/JCM.00055-16","volume":"54","author":"M du Plessis","year":"2016","unstructured":"du Plessis, M. et al. Phylogenetic analysis of invasive serotype 1 pneumococcus in South Africa, 1989 to 2013. J. Clin. Microbiol. 54, 1326\u20131334 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"15751_CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/infdis\/172.1.119","volume":"172","author":"JR Canvin","year":"1995","unstructured":"Canvin, J. R. et al. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J. Infect. Dis. 172, 119\u2013123 (1995).","journal-title":"J. Infect. Dis."},{"key":"15751_CR13","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1111\/j.1365-2958.1991.tb01969.x","volume":"5","author":"GJ Boulnois","year":"1991","unstructured":"Boulnois, G. J., Paton, J. C., Mitchell, T. J. & Andrew, P. W. Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae. Mol. Microbiol. 5, 2611\u20132616 (1991).","journal-title":"Mol. Microbiol."},{"key":"15751_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1465-9921-8-3","volume":"8","author":"M Garcia-Suarez Mdel","year":"2007","unstructured":"Garcia-Suarez Mdel, M. et al. The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model. Respir. Res. 8, 3, (2007).","journal-title":"Respir. Res."},{"key":"15751_CR15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/IAI.69.2.845-852.2001","volume":"69","author":"G Zysk","year":"2001","unstructured":"Zysk, G. et al. Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect. Immun. 69, 845\u2013852 (2001).","journal-title":"Infect. Immun."},{"key":"15751_CR16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/mpat.1998.0239","volume":"25","author":"JB Rubins","year":"1998","unstructured":"Rubins, J. B. et al. Pneumolysin in pneumococcal adherence and colonization. Microb. Pathog. 25, 337\u2013342 (1998).","journal-title":"Microb. Pathog."},{"key":"15751_CR17","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1128\/IAI.73.10.6199-6209.2005","volume":"73","author":"RK Tweten","year":"2005","unstructured":"Tweten, R. K. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun. 73, 6199\u20136209 (2005).","journal-title":"Infect. Immun."},{"key":"15751_CR18","doi-asserted-by":"crossref","first-page":"e1001191","DOI":"10.1371\/journal.ppat.1001191","volume":"6","author":"EA McNeela","year":"2010","unstructured":"McNeela, E. A. et al. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 6, e1001191, (2010).","journal-title":"PLoS Pathog."},{"key":"15751_CR19","volume":"6","author":"P Rai","year":"2016","unstructured":"Rai, P., He, F., Kwang, J., Engelward, B. P. & Chow, V. T. Pneumococcal pneumolysin induces DNA damage and cell cycle arrest. Sci. Rep. 6, 22972, (2016).","journal-title":"Sci. Rep."},{"key":"15751_CR20","doi-asserted-by":"crossref","first-page":"e0137108","DOI":"10.1371\/journal.pone.0137108","volume":"10","author":"D Fatykhova","year":"2015","unstructured":"Fatykhova, D. et al. Serotype 1 and 8 pneumococci evade sensing by inflammasomes in human lung tissue. PLoS One 10, e0137108 (2015).","journal-title":"PLoS One"},{"key":"15751_CR21","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1128\/iai.55.5.1184-1189.1987","volume":"55","author":"JA Walker","year":"1987","unstructured":"Walker, J. A., Allen, R. L., Falmagne, P., Johnson, M. K. & Boulnois, G. J. Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect. Immun. 55, 1184\u20131189 (1987).","journal-title":"Infect. Immun."},{"key":"15751_CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/mdr.1997.3.199","volume":"3","author":"R Lopez","year":"1997","unstructured":"Lopez, R., Garcia, E., Garcia, P. & Garcia, J. L. The pneumococcal cell wall degrading enzymes: a modular design to create new lysins? Microb. Drug Resist. 3, 199\u2013211 (1997).","journal-title":"Microb. Drug Resist."},{"key":"15751_CR23","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JB.01489-08","volume":"191","author":"KE Price","year":"2009","unstructured":"Price, K. E. & Camilli, A. Pneumolysin localizes to the cell wall of Streptococcus pneumoniae. J. Bacteriol. 191, 2163\u20132168 (2009).","journal-title":"J. Bacteriol."},{"key":"15751_CR24","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1128\/JB.00114-12","volume":"194","author":"KE Price","year":"2012","unstructured":"Price, K. E., Greene, N. G. & Camilli, A. Export requirements of pneumolysin in Streptococcus pneumoniae. J. Bacteriol. 194, 3651\u20133660 (2012).","journal-title":"J. Bacteriol."},{"key":"15751_CR25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1086\/527322","volume":"197","author":"RA Hirst","year":"2008","unstructured":"Hirst, R. A. et al. Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis. J. Infect. Dis. 197, 744\u2013751 (2008).","journal-title":"J. Infect. Dis."},{"key":"15751_CR26","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1128\/iai.63.5.1969-1974.1995","volume":"63","author":"AM Berry","year":"1995","unstructured":"Berry, A. M. et al. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect. Immun. 63, 1969\u20131974 (1995).","journal-title":"Infect. Immun."},{"key":"15751_CR27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1128\/IAI.68.2.492-501.2000","volume":"68","author":"A Kadioglu","year":"2000","unstructured":"Kadioglu, A. et al. Host cellular immune response to pneumococcal lung infection in mice. Infect. Immun. 68, 492\u2013501 (2000).","journal-title":"Infect. Immun."},{"key":"15751_CR28","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/iai.57.8.2324-2330.1989","volume":"57","author":"AM Berry","year":"1989","unstructured":"Berry, A. M., Lock, R. A., Hansman, D. & Paton, J. C. Contribution of autolysin to virulence of Streptococcus pneumoniae. Infect. Immun. 57, 2324\u20132330 (1989).","journal-title":"Infect. Immun."},{"key":"15751_CR29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1165\/ajrcmb\/5.5.416","volume":"5","author":"C Feldman","year":"1991","unstructured":"Feldman, C. et al. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am. J. Respir. Cell Mol. Biol. 5, 416\u2013423 (1991).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"15751_CR30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI117631","volume":"95","author":"JB Rubins","year":"1995","unstructured":"Rubins, J. B. et al. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J. Clin. Invest. 95, 142\u2013150 (1995).","journal-title":"J. Clin. Invest."},{"key":"15751_CR31","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","volume":"29","author":"E Miller","year":"2011","unstructured":"Miller, E., Andrews, N. J., Waight, P. A., Slack, M. P. & George, R. C. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine 29, 9127\u20139131 (2011).","journal-title":"Vaccine"},{"key":"15751_CR32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/IAI.69.1.426-434.2001","volume":"69","author":"NA Gingles","year":"2001","unstructured":"Gingles, N. A. et al. Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains. Infect. Immun. 69, 426\u2013434 (2001).","journal-title":"Infect. Immun."},{"key":"15751_CR33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00335-002-2261-9","volume":"14","author":"P Denny","year":"2003","unstructured":"Denny, P. et al. A major locus conferring susceptibility to infection by Streptococcus pneumoniae in mice. Mamm. Genome 14, 448\u2013453 (2003).","journal-title":"Mamm. Genome"},{"key":"15751_CR34","doi-asserted-by":"crossref","first-page":"e1002660","DOI":"10.1371\/journal.ppat.1002660","volume":"8","author":"DR Neill","year":"2012","unstructured":"Neill, D. R. et al. T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice. PLoS Pathog. 8, e1002660, (2012).","journal-title":"PLoS Pathog."},{"key":"15751_CR35","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1073\/pnas.2235844100","volume":"100","author":"FW van Ginkel","year":"2003","unstructured":"van Ginkel, F. W. et al. Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection. Proc. Natl Acad. Sci. USA 100, 14363\u201314367 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15751_CR36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/cid\/cir142","volume":"52","author":"PR Paradiso","year":"2011","unstructured":"Paradiso, P. R. Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children. Clin. Infect. Dis. 52, 1241\u20131247 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"15751_CR37","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1128\/IAI.01747-07","volume":"76","author":"A Martner","year":"2008","unstructured":"Martner, A., Dahlgren, C., Paton, J. C. & Wold, A. E. Pneumolysin released during Streptococcus pneumoniae autolysis is a potent activator of intracellular oxygen radical production in neutrophils. Infect. Immun. 76, 4079\u20134087 (2008).","journal-title":"Infect. Immun."},{"key":"15751_CR38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nbt.3037","volume":"33","author":"BD Henry","year":"2015","unstructured":"Henry, B. D. et al. Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nat. Biotechnol. 33, 81\u201388 (2015).","journal-title":"Nat. Biotechnol."},{"key":"15751_CR39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejpb.2010.10.014","volume":"77","author":"AD Lehmann","year":"2011","unstructured":"Lehmann, A. D. et al. An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. Eur. J. Pharm. Biopharm. 77, 398\u2013406 (2011).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"15751_CR40","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1083\/jcb.106.4.1141","volume":"106","author":"JM Anderson","year":"1988","unstructured":"Anderson, J. M., Stevenson, B. R., Jesaitis, L. A., Goodenough, D. A. & Mooseker, M. S. Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells. J. Cell Biol. 106, 1141\u20131149 (1988).","journal-title":"J. Cell Biol."},{"key":"15751_CR41","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1128\/IAI.01057-15","volume":"84","author":"MS Jonczyk","year":"2016","unstructured":"Jonczyk, M. S. et al. Variation in inflammatory response during Pneumococcal infection is influenced by host-pathogen interactions but associated with animal survival. Infect. Immun. 84, 894\u2013905 (2016).","journal-title":"Infect. Immun."},{"key":"15751_CR42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.73.2.201","volume":"73","author":"WB Wood","year":"1941","unstructured":"Wood, W. B. Studies on the mechanism of recovery in Pneumococcal Pneumonia: I. The action of type specific antibody upon the pulmonary lesion of experimental pneumonia. J. Exp. Med. 73, 201\u2013222 (1941).","journal-title":"J. Exp. Med."},{"key":"15751_CR43","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/iai.60.5.1740-1746.1992","volume":"60","author":"JB Rubins","year":"1992","unstructured":"Rubins, J. B., Duane, P. G., Charboneau, D. & Janoff, E. N. Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect. Immun. 60, 1740\u20131746 (1992).","journal-title":"Infect. Immun."},{"key":"15751_CR44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1083\/jcb.103.3.755","volume":"103","author":"BR Stevenson","year":"1986","unstructured":"Stevenson, B. R., Siliciano, J. D., Mooseker, M. S. & Goodenough, D. A. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J. Cell Biol. 103, 755\u2013766 (1986).","journal-title":"J. Cell Biol."},{"key":"15751_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.04.062","author":"JF Jusot","year":"2016","unstructured":"Jusot, J. F. et al. Airborne dust and high temperatures are risk factors for invasive bacterial disease. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2016.04.062 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"15751_CR46","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-10-22","volume":"10","author":"BD Gessner","year":"2010","unstructured":"Gessner, B. D., Mueller, J. E. & Yaro, S. African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infect. Dis. 10, 22, (2010).","journal-title":"BMC Infect. Dis."},{"key":"15751_CR47","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/infdis\/jit502","volume":"209","author":"B Mann","year":"2014","unstructured":"Mann, B. et al. Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein. J. Infect. Dis. 209, 1116\u20131125 (2014).","journal-title":"J. Infect. Dis."},{"key":"15751_CR48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/21645515.2016.1234553","volume":"13","author":"P Hermand","year":"2017","unstructured":"Hermand, P. et al. Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen. Hum. Vaccin. Immunother. 13, 220\u2013228 (2017).","journal-title":"Hum. Vaccin. Immunother."},{"key":"15751_CR49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0006-3002(60)91436-0","volume":"45","author":"S Lacks","year":"1960","unstructured":"Lacks, S. & Hotchkiss, R. D. Formation of amylomaltase after genetic transformation of pneumococcus. Biochim. Biophys. Acta 45, 155\u2013163 (1960).","journal-title":"Biochim. Biophys. Acta"},{"key":"15751_CR50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.imbio.2009.12.004","volume":"215","author":"L Richards","year":"2010","unstructured":"Richards, L., Ferreira, D. M., Miyaji, E. N., Andrew, P. W. & Kadioglu, A. The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. Immunobiology 215, 251\u2013263 (2010).","journal-title":"Immunobiology"},{"key":"15751_CR51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/vr.116.16.431","volume":"116","author":"DB Morton","year":"1985","unstructured":"Morton, D. B. & Griffiths, P. H. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet. Rec. 116, 431\u2013436 (1985).","journal-title":"Vet. Rec."},{"key":"15751_CR52","doi-asserted-by":"crossref","first-page":"e42244","DOI":"10.1371\/journal.pone.0042244","volume":"7","author":"JL Bose","year":"2012","unstructured":"Bose, J. L., Lehman, M. K., Fey, P. D. & Bayles, K. W. Contribution of the Staphylococcus aureus Atl AM and GL murein hydrolase activities in cell division, autolysis, and biofilm formation. PLoS One 7, e42244, (2012).","journal-title":"PLoS One"},{"key":"15751_CR53","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.4161\/cc.28401","volume":"13","author":"RA McCloy","year":"2014","unstructured":"McCloy, R. A. et al. Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. Cell Cycle 13, 1400\u20131412 (2014).","journal-title":"Cell Cycle"},{"key":"15751_CR54","doi-asserted-by":"crossref","DOI":"10.1038\/srep23671","volume":"6","author":"I Bischoff","year":"2016","unstructured":"Bischoff, I. et al. Pitfalls in assessing microvascular endothelial barrier function: impedance-based devices versus the classic macromolecular tracer assay. Sci. Rep. 6, 23671 (2016).","journal-title":"Sci. Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15751-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15751-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15751-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:46:19Z","timestamp":1670273179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15751-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["15751"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-15751-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this Article was updated shortly after publication following an error that resulted in the ORCID ID of Christopher G. Dowson being omitted.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1892"}}